Risk of Stillbirth after Infertility Treatment in the United States: 2014-2017

Authors

  • Deepa Dongarwar, MS Center of Excellence in Health Equity, Training and Research, Baylor College of Medicine, Houston, Texas, USA
  • Hamisu Mohammed Salihu, MD, PhD Center of Excellence in Health Equity, Training and Research, Baylor College of Medicine, Houston, Texas, USA; Department of Family and Community Medicine, Baylor College of Medicine, Houston, Texas, USA

DOI:

https://doi.org/10.21106/ijma.345

Keywords:

ART , Infertility treatment, Fertility enhancing drugs, Stillbirth in US

Abstract

To estimate the risk of stillbirth following infertility treatment in the United States (US), we analyzed data from the US Natality and Fetal Death files from 2014 to 2017. We built Cox proportional regression models to generate adjusted hazard ratios (HR) for the risk of stillbirth among women who utilized various modalities of infertility treatment within the study period. Women who used any infertility treatment and, specifically, assisted reproductive technology (ART), had an elevated risk of stillbirth (HR: 1.21, 95% CI:1.09 -1.33) compared to women who did not use ART. We concluded that in this population, the risk of stillbirth was elevated among women using infertility treatment.

 

Copyright © 2020 Dongarwar and Salihu. Published by Global Health and Education Projects, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution License CC BY 4.0.

Downloads

Download data is not yet available.

Downloads

Publication History

Issue

Vol. 9 No. 1

Section

Short Research Communication

License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Related Articles